EICHOR
● Completed
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Condition: Psoriatic Arthritis · Sponsor: AbbVie
About this study
This is a Phase 3 multicenter study that included two periods. Period 1 was designed to compare the safety, tolerability, and efficacy of upadacitinib 15 mg once daily (QD) and 30 mg QD versus placebo in participants with moderately to severely active Psoriatic Arthritis (PsA) who had an inadequate response to Biological Disease Modifying Anti-Rheumatic Drug (bDMARDs). Period 2 evaluated the safety, tolerability and efficacy of upadacitinib 15 mg QD and 30 mg QD in subjects with PsA who completed Period 1.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (165)
| Alabama Medical Group, PC /ID# 159836 | Mobile, Alabama, United States | — |
| Arizona Arthritis & Rheumatology Research, PLLC /ID# 160047 | Mesa, Arizona, United States | — |
| Sun Valley Arthritis Center Ltd. /ID# 161203 | Peoria, Arizona, United States | — |
| Duplicate_AZ Arthritis and Rheumotology Research, PLLC /ID# 160006 | Phoenix, Arizona, United States | — |
| Osteoporosis Medical Center /ID# 161411 | Beverly Hills, California, United States | — |
| Covina Arthritis Clinic /ID# 159919 | Covina, California, United States | — |
| Triwest Research Associates /ID# 159915 | El Cajon, California, United States | — |
| Duplicate_Providence Medical Foundation /ID# 160005 | Fullerton, California, United States | — |
| C.V. Mehta MD, Med Corporation /ID# 161192 | Hemet, California, United States | — |
| Care Access Research, Huntington Beach /ID# 160049 | Huntington Beach, California, United States | — |
| Purushotham & Akther Kotha MD, Inc /ID# 159834 | La Mesa, California, United States | — |
| Stanford University School of Med /ID# 161402 | Stanford, California, United States | — |
+ 153 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03104374